219 related articles for article (PubMed ID: 10360647)
1. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
Hung WC; Chuang LY
Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
[TBL] [Abstract][Full Text] [Related]
2. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation.
Legrand A; Vadrot N; Lardeux B; Bringuier AF; Guillot R; Feldmann G
Liver Int; 2004 Apr; 24(2):149-60. PubMed ID: 15078480
[TBL] [Abstract][Full Text] [Related]
3. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
[TBL] [Abstract][Full Text] [Related]
4. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells.
Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H
Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
[TBL] [Abstract][Full Text] [Related]
7. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo.
Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T
Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278
[TBL] [Abstract][Full Text] [Related]
11. Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon beta in human cancer cells.
Choi EA; Lei H; Maron DJ; Wilson JM; Barsoum J; Fraker DL; El-Deiry WS; Spitz FR
Cancer Res; 2003 Sep; 63(17):5299-307. PubMed ID: 14500361
[TBL] [Abstract][Full Text] [Related]
12. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
13. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
Huang Y; Horvath CM; Waxman S
Cancer Res; 2000 Jun; 60(12):3200-6. PubMed ID: 10866311
[TBL] [Abstract][Full Text] [Related]
14. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
[TBL] [Abstract][Full Text] [Related]
15. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
Koike K; Takaki A; Tatsukawa M; Suzuki M; Shiraha H; Iwasaki Y; Sakaguchi K; Shiratori Y
Int J Oncol; 2006 Nov; 29(5):1253-61. PubMed ID: 17016659
[TBL] [Abstract][Full Text] [Related]
16. Butyrate augments interferon-alpha-induced S phase accumulation and persistent tyrosine phosphorylation of cdc2 in K562 cells.
Miyachi T; Adachi M; Hinoda Y; Imai K
Br J Cancer; 1999 Mar; 79(7-8):1018-24. PubMed ID: 10098730
[TBL] [Abstract][Full Text] [Related]
17. IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.
Fulda S; Debatin KM
Oncogene; 2002 Apr; 21(15):2295-308. PubMed ID: 11948413
[TBL] [Abstract][Full Text] [Related]
18. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
[TBL] [Abstract][Full Text] [Related]
19. Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.
Chelbi-alix MK; Bobé P; Benoit G; Canova A; Pine R
Oncogene; 2003 Dec; 22(57):9121-30. PubMed ID: 14668793
[TBL] [Abstract][Full Text] [Related]
20. STAT1: a modulator of chemotherapy-induced apoptosis.
Thomas M; Finnegan CE; Rogers KM; Purcell JW; Trimble A; Johnston PG; Boland MP
Cancer Res; 2004 Nov; 64(22):8357-64. PubMed ID: 15548705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
